Evidence map›Paper›PMID 36233085›Full record

ArticleInternational journal of molecular sciences2022

Development of Two Innovative Performance-Based Objective Measures in Feline Osteoarthritis: Their Reliability and Responsiveness to Firocoxib Analgesic Treatment.

Aliénor Delsart, Maxim Moreau, Colombe Otis, Marilyn Frezier, Marlene Drag, Jean-Pierre Pelletier, Johanne Martel-Pelletier, Bertrand Lussier, Jérôme Del Castillo, Eric Troncy

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Research of Pathogenesis and Novel Therapeutics in Arthritis 3.0.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Aliénor DelsartGroupe de Recherche en Pharmacologie Animale du Québec (GREPAQ), Department of Biomedical Sciences, Faculty of Veterinary Medicine, Université de Montréal, St.-Hyacinthe, QC J2S 2M2, Canada.
Maxim MoreauGroupe de Recherche en Pharmacologie Animale du Québec (GREPAQ), Department of Biomedical Sciences, Faculty of Veterinary Medicine, Université de Montréal, St.-Hyacinthe, QC J2S 2M2, Canada.
Colombe OtisGroupe de Recherche en Pharmacologie Animale du Québec (GREPAQ), Department of Biomedical Sciences, Faculty of Veterinary Medicine, Université de Montréal, St.-Hyacinthe, QC J2S 2M2, Canada.ORCID 0000-0003-4286-6534
Marilyn FrezierGroupe de Recherche en Pharmacologie Animale du Québec (GREPAQ), Department of Biomedical Sciences, Faculty of Veterinary Medicine, Université de Montréal, St.-Hyacinthe, QC J2S 2M2, Canada.
Marlene DragBoehringer Ingelheim Animal Health, Fulton, MO 65251, USA.
Jean-Pierre PelletierOsteoarthritis Research Unit, University of Montreal Hospital Research Center (CRCHUM), Montréal, QC H2X 0A9, Canada.
Johanne Martel-PelletierOsteoarthritis Research Unit, University of Montreal Hospital Research Center (CRCHUM), Montréal, QC H2X 0A9, Canada.ORCID 0000-0003-2618-383X
Bertrand LussierGroupe de Recherche en Pharmacologie Animale du Québec (GREPAQ), Department of Biomedical Sciences, Faculty of Veterinary Medicine, Université de Montréal, St.-Hyacinthe, QC J2S 2M2, Canada.
Jérôme Del CastilloGroupe de Recherche en Pharmacologie Animale du Québec (GREPAQ), Department of Biomedical Sciences, Faculty of Veterinary Medicine, Université de Montréal, St.-Hyacinthe, QC J2S 2M2, Canada.
Eric TroncyGroupe de Recherche en Pharmacologie Animale du Québec (GREPAQ), Department of Biomedical Sciences, Faculty of Veterinary Medicine, Université de Montréal, St.-Hyacinthe, QC J2S 2M2, Canada.ORCID 0000-0003-0209-5261
Université de Montréal · CABoehringer Ingelheim (United States) · US

Funding

Canada Foundation for Innovation # 24601Canada Foundation for Innovation # 9483Mitacs #IT 11643Natural Sciences and Engineering Research Council #RDCPJ 491953-2016Natural Sciences and Engineering Research Council #RGPIN 05512-2020Natural Sciences and Engineering Research Council #RGPIN 441651-2013
6 · The paper itself

Abstract

The metrological properties of two performance-based outcome measures of feline osteoarthritis (OA), namely Effort Path (Path) and Stairs Assay Compliance (Stairs), were tested. Cats naturally affected by OA (n = 32) were randomly distributed into four groups (A: 0.40, B: 0.25, C: 0.15, or D: 0.00 mg firocoxib/kg bodyweight) and assessed during baseline, treatment, and recovery periods. For Path, from an elevated walking platform, the cats landed on a pressure-sensitive mattress and jumped up onto a second elevated platform. Analysis included velocity, time to completion, peak vertical force (PVF), and vertical impulse. For Stairs, the number of steps and time to completion were recorded for 16 steps up and down in a 4 min period. Reliability was moderate to very good for Path and poor to good for Stairs. Different normalization methods are described in the manuscript. The placebo group remained stable within-time in Path, whereas treated cats trotted faster on the ramp (p < 0.0001), improved their PVF (p < 0.018) and completed the task quicker (p = 0.003). The percentage of cats completing the Stairs finish line was higher under treatment (p < 0.036), with huge effect size, the placebo group results being stable within-time. Both are promising performance-based outcome measures to better diagnose and manage feline OA pain.

Indexed as

Osteoarthritis4-ButyrolactoneAnalgesicsAnimalsCatsReproducibility of ResultsSulfones4-ButyrolactoneAnalgesicsfirocoxibSulfonesfelinefirocoxibgait analysisosteoarthritisperformancestairs

Identifiers

PMID36233085
PMCPMC9569873
OpenAlexW4303699640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.